Researchers report the first-ever total synthesis of a promising mushroom-derived compound
Natural compounds from plants and animals have long been used in drug development, but mushrooms remain underexplored despite their rich chemical potential. Now, researchers from Japan have ...
Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today. The rally ...
bovnews1h
This Biotech Stock is Defying the Odds—Find Out Why ImmunoPrecise Antibodies (IPA) is Trending Today
ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...
Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response including a 17.2% complete response rate – – Antitumor ...
STAT8h
Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets
Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...
verywellhealth22h
Injectable Alzheimer's Drugs Could Save Patients Trips to the Hospital
Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...